Chief Scientific Officer, The US Oncology Network, McKesson Corporation

The Woodlands, Texas
Aug 19, 2019
Sep 19, 2019
Full Time

The US Oncology Network is looking for a nationally recognized oncologist with a track record of excellence in clinical research and drug development to serve as Chief Scientific Officer. This role supports The US Oncology Network, US Oncology Research (USOR) and McKesson as we continue to enhance our clinical research program across a national network of oncology practices. This leader will be charged with continuing our journey to build an internationally recognized research program and a stronger culture of research within a group of 2,000 cancer care clinicians. The successful candidate for this position will have the opportunity to impact the direction of cancer care on a national scale.

The Chief Scientific Officer will lead US Oncology Research (USOR) organization within US Oncology. Through the program, more than 77,000 patients have enrolled in clinical trials, including approximately 3,000–6,000 patients enrolled in roughly 300 open clinical trials annually. USOR has participated in one-third of all the pivotal trials underpinning FDA approval of oncology drugs over the last decade. The centralized USOR team located in The Woodlands, Texas, manages contracts, regulatory issues and program management while coordinating with two USOR dedicated independent institutional review boards. Physician investigators conduct research at more than 150 sites in The Network, supported by several hundred research nurses, clinical research associates and data managers. The program reviews 400 trial concepts vetted by our clinical research program leaders in Early Development, Developmental Therapeutics and Breast, Thoracic, Gastrointestinal, Genitourinary, Gynecologic, and Hematology

The Chief Scientific Officer (CSO) will be the senior-most clinician scientist on The US Oncology Network leadership team and will have a broad set of responsibilities including participating on The Network and McKesson leadership teams and collaborating with physicians within The Network, and manufacturers, laboratory companies and device companies. Finally, a qualified candidate for this role will be forward-thinking and strategic in evaluating emerging technologies--including consumer-facing technologies, digital platforms and artificial intelligence strategies—that might accelerate the conduct of research within The US Oncology Network.

Interested applicants such forward a cover letter and their CV to